Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 737,500 shares, a drop of 25.1% from the May 15th total of 985,200 shares. Currently, 3.7% of the company's shares are sold short. Based on an average daily volume of 169,800 shares, the short-interest ratio is presently 4.3 days.
Rapid Micro Biosystems Stock Performance
NASDAQ RPID traded up $0.19 during trading on Friday, hitting $3.32. The stock had a trading volume of 116,334 shares, compared to its average volume of 195,746. The stock has a market capitalization of $145.52 million, a price-to-earnings ratio of -3.22 and a beta of 1.33. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.04. The stock has a 50 day simple moving average of $2.96 and a 200 day simple moving average of $2.32.
Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.01. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. The firm had revenue of $7.21 million during the quarter, compared to the consensus estimate of $6.63 million. On average, sell-side analysts predict that Rapid Micro Biosystems will post -1.1 EPS for the current year.
Institutional Trading of Rapid Micro Biosystems
Several institutional investors and hedge funds have recently modified their holdings of RPID. Renaissance Technologies LLC raised its stake in shares of Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after acquiring an additional 100,942 shares in the last quarter. Citadel Advisors LLC bought a new stake in shares of Rapid Micro Biosystems during the fourth quarter valued at approximately $65,000. Millennium Management LLC raised its stake in shares of Rapid Micro Biosystems by 17.6% during the fourth quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after acquiring an additional 9,191 shares in the last quarter. Legato Capital Management LLC bought a new stake in shares of Rapid Micro Biosystems during the first quarter valued at approximately $41,000. Finally, Essex Investment Management Co. LLC bought a new stake in shares of Rapid Micro Biosystems during the first quarter valued at approximately $166,000. Institutional investors own 52.60% of the company's stock.
About Rapid Micro Biosystems
(
Get Free Report)
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Read More
Before you consider Rapid Micro Biosystems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.
While Rapid Micro Biosystems currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.